Subsequent events (Details Narrative) - USD ($) |
12 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Mar. 11, 2025 |
Feb. 28, 2025 |
Feb. 20, 2025 |
Feb. 19, 2025 |
Feb. 06, 2025 |
Dec. 31, 2024 |
Mar. 21, 2025 |
|
Subsequent Event [Line Items] | |||||||
Purchase price acquisition | $ 399,713 | ||||||
Subsequent Event [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Principal amount | $ 400,000 | ||||||
Interest rate | 11.00% | ||||||
Proceeds from sale of businesses | $ 8,100,000 | ||||||
Cash | $ 6,500,000 | ||||||
Royalty percentage | 5.50% | 3.00% | |||||
Royalty payment per year | $ 300,000 | ||||||
Royalty total payment | $ 1,700,000 | ||||||
All stock transaction value | $ 80,000,000 | ||||||
Debt net | 43,000,000 | ||||||
Consideration for transaction | $ 30,000,000.0 | ||||||
Purchase price acquisition | 30,000,000 | ||||||
Subsequent Event [Member] | Specialty Pharmacy Group [Member] | |||||||
Subsequent Event [Line Items] | |||||||
Business acquisition, percentage | 100.00% | ||||||
Purchase price acquisition | $ 4,700,000 |
X | ||||||||||
- Definition Royalty percentage. No definition available.
|
X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of authorized capital units or capital shares. This element is relevant to issuers of face-amount certificates and registered investment companies. No definition available.
|
X | ||||||||||
- Definition Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of debt and lease obligation, classified as current. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face (par) amount of debt instrument at time of issuance. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The average effective interest rate during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of cash paid for royalties during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Cash received on stock transaction after deduction of issuance costs. No definition available.
|
X | ||||||||||
- Definition Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination. No definition available.
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|